Skip to content

S. 2454 · 118th Congress (2023–2025)

Pharmaceutical Supply Chain Security Act

This bill directs certain agencies to report on and reduce the role of China in pharmaceutical supply chains.

Specifically, the Food and Drug Administration must report on pharmaceutical products and ingredients for which China supplies more than 20% of the quantities available in the United States. In addition, the President must develop a strategy to address the role of China in the global pharmaceutical supply chain and related threats to national security. The United States International Development Finance Corporation must also support manufacturing projects that promote the security of pharmaceutical supply chains, reduce reliance on China, and foster cooperation with other countries.

Show official title

A bill to require reports on and investments in pharmaceutical supply chain resiliency to reduce reliance on the People's Republic of China for finished pharmaceutical products and active pharmaceutical ingredients.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReferred to committee

This bill’s path

This is S. 2454’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. James Lankford (R-OK)
Cosponsors
1 cosponsor

0 original · 1 later

  1. Sen. Gary C. Peters (D-MI)· Later · Dec 16, 2024
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest

    Referred to committee

    Read twice and referred to the Committee on Foreign Relations.

    Sources
  3. Expired

    Introduced → Referred to Senate Foreign Relations → No further action before the 118th Congress ended.

Committees

  1. SenateForeign RelationsReferred Jul 20, 2023

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Titles (2)
  1. Pharmaceutical Supply Chain Security Act

    Display title, Short title · Introduced in Senate

  2. A bill to require reports on and investments in pharmaceutical supply chain resiliency to reduce reliance on the People's Republic of China for finished pharmaceutical products and active pharmaceutical ingredients.

    Official title · Introduced in Senate